$2.26
-0.09[-3.83%]
At close: Apr 25
$2.26
0[0.00%]
After Hours: 4:38PM EDT
Taysha Gene Therapies
(NASDAQ:TSHA)Taysha Gene Therapies Stock (NASDAQ:TSHA), Earnings Estimates, EPS, and Revenue
Taysha Gene Therapies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$-0.060
Quarterly Revenue Estimate
$1.9M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$15.5M
Analyze the earnings history of Taysha Gene Therapies using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | PM | TSHA | Q1 | -$0.28 | -$0.06 | — | — | $4.71M | $1.92M | — | — | Get Alert |
| 03/19/2024 | PM | TSHA | Q4 | -$0.34 | -$0.11 | $0.92 | 936.36% | $2.50M | $2.65M | $3.60M | 36.00% | Get Alert |
| 11/14/2023 | PM | TSHA | Q3 | -$0.64 | -$0.17 | -$0.93 | -447.06% | $0.00 | $1.40M | $4.75M | 239.00% | Get Alert |
| 08/14/2023 | AM | TSHA | Q2 | -$0.84 | -$0.31 | -$0.38 | -22.58% | $0.00 | $2.00M | $2.40M | 19.75% | Get Alert |
| 05/11/2023 | PM | TSHA | Q1 | -$1.31 | -$0.35 | -$0.28 | 20.00% | $0.00 | $70.00K | $4.71M | 6622.86% | Get Alert |
| 03/28/2023 | PM | TSHA | Q4 | -$1.32 | -$0.33 | -$0.34 | -3.03% | $0.00 | $8.18M | $2.50M | -69.41% | Get Alert |
| 11/08/2022 | AM | TSHA | Q3 | -$1.35 | -$0.82 | -$0.64 | 21.95% | $0.00 | — | $0.00 | — | Get Alert |
| 08/11/2022 | AM | TSHA | Q2 | -$1.09 | -$0.91 | -$0.84 | 7.69% | $0.00 | — | $0.00 | — | Get Alert |
| 05/16/2022 | AM | TSHA | Q1 | -$0.87 | -$1.07 | -$1.31 | -22.43% | $0.00 | — | $0.00 | — | Get Alert |
| 03/31/2022 | AM | TSHA | Q4 | -$1.04 | -$1.25 | -$1.32 | -5.60% | $0.00 | — | $0.00 | — | Get Alert |
| 11/10/2021 | AM | TSHA | Q3 | -$1.28 | -$1.08 | -$1.35 | -25.00% | $0.00 | — | $0.00 | — | Get Alert |
| 08/16/2021 | AM | TSHA | Q2 | — | -$0.84 | -$1.09 | -29.76% | — | — | $0.00 | — | Get Alert |
| 05/11/2021 | AM | TSHA | Q1 | — | -$0.56 | -$0.87 | -55.36% | — | — | $0.00 | — | Get Alert |
| 03/03/2021 | AM | TSHA | Q4 | — | -$0.37 | -$1.04 | -181.08% | — | — | $0.00 | — | Get Alert |
| 11/12/2020 | PM | TSHA | Q3 | — | — | -$1.28 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?
Taysha Gene Therapies (TSHA) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 19, 2024 for Q4.
What were the latest earnings per share (EPS) for Taysha Gene Therapies (NASDAQ:TSHA)?
The Actual EPS was $0.92, which beat the estimate of $-0.11.
What were Taysha Gene Therapies’s (NASDAQ:TSHA) revenues?
The Actual Revenue was $3.6M, which beat the estimate of $2.6M.
Browse earnings estimates, EPS, and revenue on all stocks.